An update from Moderna ( (MRNA)) is now available. In a January 5, 2026 letter to shareholders, Moderna reviewed a challenging 2025 operating environment in the U.S. but highlighted strong execution ...

Hawaii’s new tourist tax has come into force. The tax is seeking to raise money to help address potential ramifications of climate change in the nation’s first “Green Fee” levy, designed to help ...

HONOLULU (HawaiiNewsNow) - Thirteen new Hawaii laws taking effect Jan. 1 will raise costs for tourists and uninsured drivers while expanding protections for families and consumers. Hawaii’s new “Green ...

Moderna stock soared in the early stages of the pandemic, then struggled -- but in recent times, it’s been on the rise. This other biotech has proven itself as a long-term winner. 10 stocks we like ...

Moderna stock soared in the early stages of the pandemic, then struggled -- but in recent times, it’s been on the rise. This other biotech has proven itself as a long-term winner. This stock is a ...

Initiate Moderna with a Hold rating at a $25 target price (lower than the current price), citing balanced risk-reward despite the advanced mRNA platform and robust pipeline. MRNA's near-term execution ...

HONOLULU (HawaiiNewsNow) -After clearing legal hurdles, a new state law imposing higher taxes for tourists is on track to go into effect in the new year. The Green Fee will increase the transient ...

A federal judge's ruling clears the way for Hawaii to include cruise ship passengers in a new tourist tax to help pay for the impacts of climate change, a levy set to go into effect at the start of ...

Moderna has rallied ~23%, but I maintain a 'Sell' and 'market underperform' rating due to deteriorating fundamentals. MRNA’s recent rally is driven by improved liquidity, cost discipline, and a $1.5 ...

Musician and Uber driver Corey Strickland waits outside Daniel K. Inouye International Airport. Strickland, 38, lives with two roommates and is debt-free but has no savings for retirement. At top, ...

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups could help fill the void after the Trump administration slashed federal ...